SEMINARS IN LIVER DISEASE

Scope & Guideline

Delivering critical insights for liver disease advancements.

Introduction

Welcome to your portal for understanding SEMINARS IN LIVER DISEASE, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0272-8087
PublisherTHIEME MEDICAL PUBL INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1981 to 2024
AbbreviationSEMIN LIVER DIS / Semin. Liver Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address333 SEVENTH AVE, NEW YORK, NY 10001

Aims and Scopes

The journal 'SEMINARS IN LIVER DISEASE' is dedicated to advancing the understanding of liver diseases through comprehensive research articles, reviews, and clinical insights. It aims to bridge the gap between basic science and clinical practice, focusing on innovative therapeutic strategies and the molecular underpinnings of liver pathologies.
  1. Liver Disease Mechanisms and Pathophysiology:
    The journal emphasizes understanding the underlying biological mechanisms of liver diseases, including metabolic dysfunction, inflammation, and fibrosis, to inform therapeutic approaches.
  2. Clinical Management and Treatment Strategies:
    A core focus is on the clinical management of liver diseases, discussing treatment options, patient care strategies, and recent advancements in therapy.
  3. Innovative Diagnostic Approaches:
    The journal explores novel diagnostic methods, including non-invasive tests and biomarkers, to improve early detection and monitoring of liver diseases.
  4. Transplantation and Regenerative Medicine:
    Research on liver transplantation, advancements in regenerative medicine, and the use of stem cell therapies are significant themes, highlighting their role in treating end-stage liver diseases.
  5. Emerging Therapies and Precision Medicine:
    There is a consistent focus on precision medicine, exploring targeted therapies and personalized treatment plans based on genetic and molecular profiling of liver diseases.
  6. Interdisciplinary Research and Collaboration:
    The journal encourages interdisciplinary research that combines hepatology with fields such as immunology, oncology, and microbiology, fostering collaboration between researchers and clinicians.
The journal has identified various trending and emerging themes that reflect the evolving landscape of liver disease research. These themes are indicative of current priorities in the field and highlight areas of significant growth and interest.
  1. Metabolic Dysfunction-Associated Liver Disease (MASLD):
    Recent publications show an increasing focus on MASLD, emphasizing its clinical significance, diagnostic challenges, and treatment strategies, reflecting a broader recognition of metabolic factors in liver disease.
  2. Immunotherapy and Liver Cancer:
    The rise in studies exploring the role of immunotherapy and immune checkpoint inhibitors in liver cancer treatment showcases a growing interest in harnessing the immune system to combat liver malignancies.
  3. Non-Invasive Biomarkers and Diagnostic Tools:
    There is a marked trend towards developing and validating non-invasive biomarkers for liver disease assessment, aligning with the need for safer and more accessible diagnostic methods.
  4. Integrative Approaches to Liver Health:
    Emerging themes highlight integrative approaches that combine lifestyle, microbiome research, and metabolic health with liver disease management, indicating a holistic view of liver health.
  5. Single-Cell and Spatial Omics Techniques:
    The adoption of advanced techniques like single-cell and spatial transcriptomics is on the rise, allowing for deeper insights into liver biology and disease mechanisms at an unprecedented resolution.

Declining or Waning

While 'SEMINARS IN LIVER DISEASE' is growing in several areas, certain themes appear to be declining in prominence, indicating a shift in focus within the journal's scope.
  1. Traditional Hepatitis Treatments:
    As newer therapies and more effective treatments for hepatitis B and C emerge, traditional treatment discussions have become less frequent, reflecting a shift towards discussing innovative therapies and their implications.
  2. Generalized Dietary Recommendations:
    Specific dietary guidelines for liver disease management have seen a decline, possibly as the focus shifts to personalized nutrition approaches that consider individual patient needs.
  3. Basic Hepatology Principles:
    There is a noticeable reduction in the publication of foundational hepatology topics, as the journal increasingly prioritizes cutting-edge research and clinical applications.
  4. Complications of Cirrhosis:
    Discussions surrounding complications of cirrhosis, while still relevant, have become less frequent as the journal pivots towards more specialized topics like metabolic dysfunction and liver cancer.
  5. Historical Reviews on Liver Diseases:
    The journal appears to be moving away from extensive historical reviews towards contemporary studies and future directions, reflecting a trend towards current research and innovations.

Similar Journals

Journal of Clinical and Translational Hepatology

Advancing hepatology for better patient outcomes.
Publisher: XIA & HE PUBLISHING INCISSN: 2225-0719Frequency: 12 issues/year

Journal of Clinical and Translational Hepatology is an esteemed publication dedicated to advancing the field of hepatology through innovative research and clinical insights. Published by XIA & HE PUBLISHING INC, this journal connects researchers and healthcare professionals in the exploration of liver diseases and their management. With an impact factor that reflects its significant contribution to the discipline, the Journal holds a commendable Q2 classification in Hepatology as of 2023, and it ranks highly in both Gastroenterology and Hepatology categories on Scopus, positioning it within the top 80th percentile of its field. Although the journal is not open access, it provides its audience with invaluable information, encouraging collaboration that aims to translate clinical findings into transformative patient care. With a publication history spanning from 2013 to 2024, the Journal of Clinical and Translational Hepatology has established itself as a vital resource for researchers, clinicians, and students alike, making it a prominent voice in the hepatological community.

ZEITSCHRIFT FUR GASTROENTEROLOGIE

Elevating Research Standards in Gastroenterology
Publisher: GEORG THIEME VERLAG KGISSN: 0044-2771Frequency: 12 issues/year

ZEITSCHRIFT FUR GASTROENTEROLOGIE, published by GEORG THIEME VERLAG KG, stands as a notable journal in the field of gastroenterology since its inception in 1971. With an ISSN of 0044-2771 and an E-ISSN of 1439-7803, this journal focuses on advancing knowledge and research in gastrointestinal health. Operating from Germany, its contributions span various aspects of gastroenterology, providing a platform for both established and emerging scholars to share their findings. As of 2023, ZEITSCHRIFT FUR GASTROENTEROLOGIE is ranked in the Q3 quartile in Gastroenterology and Q4 in Medicine (miscellaneous), reflecting its critical yet developing role in the academic community. Despite its current Scopus rank of #117 out of 167 in the gastroenterology category, the journal aims to foster innovative research and discussions vital for tackling contemporary challenges in gastrointestinal medicine. While it does not offer open access, the journal's extensive archival rigor ensures that pertinent studies remain accessible to professionals and academicians seeking to deepen their understanding and engage with evolving clinical practices.

JGH Open

Pioneering Open Access in Gastroenterology and Hepatology
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

Cellular and Molecular Gastroenterology and Hepatology

Transforming the landscape of gastroenterology and hepatology.
Publisher: ELSEVIER INCISSN: 2352-345XFrequency: 12 issues/year

Cellular and Molecular Gastroenterology and Hepatology, published by Elsevier Inc, is a premier Open Access journal dedicated to advancing the understanding and treatment of gastrointestinal and liver diseases. Since its inception in 2015, this journal has established itself as a leading publication within its field, boasting impressive metrics with a 2023 Q1 ranking in both Gastroenterology and Hepatology. It ranks #10 out of 167 in Gastroenterology and #11 out of 82 in Hepatology on Scopus, placing it in the 94th and 87th percentiles, respectively. This journal aims to disseminate high-quality, peer-reviewed research that fosters innovative solutions for clinical challenges, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access, all published content is readily available to a global audience, ensuring that critical findings in cellular and molecular biology related to gastroenterology and hepatology reach those who can benefit the most from the latest advances in the field. For more information, please visit us at our address in San Diego, CA, or explore our articles online.

Expert Review of Gastroenterology & Hepatology

Navigating the Evolving Landscape of Digestive Medicine
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-4124Frequency: 8 issues/year

Expert Review of Gastroenterology & Hepatology is a premier journal published by Taylor & Francis Ltd that aims to bridge the gap between clinical practice and research in the fields of gastroenterology and hepatology. Established in 2007, this journal has rapidly gained recognition, boasting a Q1 ranking in Gastroenterology and a Q2 ranking in Hepatology for 2023, while achieving impressive Scopus rankings of 31st and 25th respectively in these disciplines, placing it within the top 81st and 70th percentiles. The journal’s objective is to provide a comprehensive platform for the latest developments, innovative treatments, and critical reviews, catering to researchers, healthcare professionals, and students alike. Located in the United Kingdom, the journal does not operate under an open access model but ensures that its content is accessible to a global audience through institutional subscriptions. By consistently publishing high-impact reviews and articles, Expert Review of Gastroenterology & Hepatology solidifies its role as a vital resource in advancing knowledge and clinical practice within these challenging and evolving fields.

International Journal of Hepatology

Bridging research and clinical practice in hepatology.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

Hepatobiliary & Pancreatic Diseases International

Championing excellence in hepatobiliary and pancreatic research.
Publisher: ELSEVIERISSN: 1499-3872Frequency: 6 issues/year

Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.

Hepatology International

Elevating global hepatology research to new heights.
Publisher: SPRINGERISSN: 1936-0533Frequency: 4 issues/year

Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.

Journal of Clinical and Experimental Hepatology

Connecting experts to elevate the field of hepatology.
Publisher: ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTDISSN: 0973-6883Frequency: 4 issues/year

The Journal of Clinical and Experimental Hepatology, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a premier platform dedicated to advancing the field of hepatology. With an ISSN of 0973-6883 and an E-ISSN of 2213-3453, this journal has gained recognition for its impactful contributions to both clinical practice and scientific research in the domain of liver health. Ranking in the Q2 quartile for Hepatology in 2023 and positioned at 33rd out of 82 in Scopus’s Hepatology category, it reflects a robust impact factor and a commitment to publishing high-quality, peer-reviewed articles. Researchers, clinicians, and students can engage with a wealth of open-access content covering the latest advancements, challenges, and insights in hepatology, as the journal aims to disseminate knowledge from 2011 through 2025. Join the community of experts as we explore critical developments in the understanding and treatment of liver diseases.

Hepatology Forum

Illuminating the path to better liver health.
Publisher: KARE PUBLISSN: 1307-5888Frequency: 4 issues/year

Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.